Next Article in Journal
Actinic Keratosis and Non-Invasive Diagnostic Techniques: An Update
Next Article in Special Issue
Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets
Previous Article in Journal
Programming of Cell Resistance to Genotoxic and Oxidative Stress
Previous Article in Special Issue
Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessReview
Biomedicines 2018, 6(1), 7; https://doi.org/10.3390/biomedicines6010007

Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies

Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA
*
Author to whom correspondence should be addressed.
Received: 8 November 2017 / Revised: 21 December 2017 / Accepted: 23 December 2017 / Published: 3 January 2018
(This article belongs to the Special Issue Cancer Biomarkers and Targets in Digestive Organs)
Full-Text   |   PDF [210 KB, uploaded 3 January 2018]   |  

Abstract

The role of external beam radiation therapy (EBRT) in the management of upper gastrointestinal malignancies is constantly evolving. As radiation therapy techniques improve and are able to deliver more ablative doses of radiotherapy while sparing healthy tissue, radiation can be applied to a wider range of clinical scenarios. Stereotactic body radiation therapy (SBRT) allows a high dose of radiation to be delivered to a highly conformal treatment volume in a short amount of time. Another potential advantage of SBRT is its ability to increase tumor immunogenicity, while also having less of an immunosuppressive effect on the patient, as compared to conventionally fractionated radiation therapy. In so doing, SBRT may potentiate the effects of immune therapy when the two treatments are combined, thus improving therapeutic outcomes. This article provides an overview of the role of SBRT in the management of upper gastrointestinal GI malignancies and the emerging data on immune biomarkers and SBRT, with a focus on pancreatic and liver cancer. View Full-Text
Keywords: stereotactic body radiation therapy; immunotherapy; biomarkers stereotactic body radiation therapy; immunotherapy; biomarkers
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Tchelebi, L.; Zaorsky, N.; Mackley, H. Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies. Biomedicines 2018, 6, 7.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top